The latest news for pharma industry insiders.
How Efficient Logistics Can Change the Lives of Rare Disease Patients
If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.
More than a Third of Americans Have Skipped a Healthcare Visit Due to Inability to Pay
The average American can afford a maximum of a $97 for out-of-pocket healthcare expenses.
In Battle Over Health Care Costs, Private Equity Plays Both Sides
As medical practices owned by private equity firms fuel overbilling, a payment tool also backed by such investors helps insurers boost their profits.
MedQuest Names Aalpen Patel Chief Clinical and Innovation Officer
MedQuest Associates (MedQuest), has selected Dr. Aalpen Patel as Chief Clinical and Innovation Officer. Dr. Patel joined on March 18 in a new role overseeing all functions related to clinical practices and innovation in product development and care delivery. He reports to CEO Jason Howard and serves on the company’s Executive Leadership Council.
Brigitte Mittwich on LinkedIn:
Conversations like Marie Teil’s on the Pharmaceutical Executive podcast are crucial in shedding light on the data gap faced by women of childbearing age and opportunities for change. Listen below!
https://lnkd.in/e2Q_sMbj
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.